Envoy Medical COCH Net Income Loss Available To Common Stockholders Diluted
Net Income Loss Available To Common Stockholders Diluted at other companies
Other financials
Where this comes from
Reported directly by Envoy Medical in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted.
The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Envoy Medical's net income loss available to common stockholders diluted.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Envoy Medical's net income loss available to common stockholders diluted?
- Envoy Medical (COCH) reported net income loss available to common stockholders diluted of -$5.7M in Q1 2026.
- How has Envoy Medical's net income loss available to common stockholders diluted changed year-over-year?
- Envoy Medical's net income loss available to common stockholders diluted increased by 8.6% year-over-year, from -$6.24M to -$5.7M.
- What is the long-term trend for Envoy Medical's net income loss available to common stockholders diluted?
- Over 2 years (2023 to 2025), Envoy Medical's net income loss available to common stockholders diluted has grown at a -4.4% compound annual growth rate (CAGR), from -$31.34M to -$28.66M.
- What does net income loss available to common stockholders diluted mean?
- Calculates the net income or loss attributable to common shareholders after accounting for preferred dividends and the potential dilutive effect of all convertible securities. This is the primary measure of bottom-line performance from the perspective of common equity holders. It provides a comprehensive view of profitability after all capital structure obligations are satisfied.